T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Hanover Insurance
THG
$7.74B
| $7.12M | ﹤0.01% |
55,559
-1,033,223
| -95% | -$140M |
|
|
EXAI
1127
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $7.1M | ﹤0.01% |
864,921
-5,723
| -0.7% | -$57.7K |
|
|
SWTX
1128
DELISTED
SpringWorks Therapeutics
SWTX
| $7.1M | ﹤0.01% |
248,855
+7,412
| +3% | +$213K |
|
1129
Badger Meter
BMI
$3.91B
| $7.06M | ﹤0.01% |
76,362
-124,417
| -62% | -$11.5M |
|
|
CANO
1130
DELISTED
Cano Health, Inc.
CANO
| $7.04M | ﹤0.01% |
8,114
+7,302
| +899% | +$4.58M |
|
1131
National Bank Holdings
NBHC
$1.92B
| $6.99M | ﹤0.01% |
188,899
-2,697,358
| -93% | -$108M |
|
1132
CareDx
CDNA
$2.45B
| $6.94M | ﹤0.01% |
407,763
-682
| -0.2% | -$14.6K |
|
1133
Robinhood
HOOD
$89.3B
| $6.94M | ﹤0.01% |
686,751
-142,805
| -17% | -$1.37M |
|
1134
Roku
ROKU
$22.9B
| $6.93M | ﹤0.01% |
122,875
-19,997
| -14% | -$1.52M |
|
1135
MoonLake Immunotherapeutics
MLTX
$1.47B
| $6.92M | ﹤0.01% |
869,388
-1,136
| -0.1% | -$8.03K |
|
|
PYCR
1136
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $6.91M | ﹤0.01% |
233,728
-5,153,273
| -96% | -$149M |
|
1137
Azenta
AZTA
$1.47B
| $6.91M | ﹤0.01% |
161,150
-483,811
| -75% | -$28.9M |
|
1138
Full Truck Alliance
YMM
$9.2B
| $6.86M | ﹤0.01% |
+1,046,489
| New | +$8.07M |
|
|
BLSA
1139
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $6.79M | ﹤0.01% |
677,715
-2,406
| -0.4% | -$24K |
|
1140
DaVita
DVA
$11.6B
| $6.72M | ﹤0.01% |
81,238
-11,001
| -12% | -$965K |
|
1141
ChargePoint
CHPT
$166M
| $6.68M | ﹤0.01% |
22,641
+1,844
| +9% | +$560K |
|
1142
Newell Brands
NWL
$2.62B
| $6.59M | ﹤0.01% |
474,674
-12,536
| -3% | -$234K |
|
1143
Equinor
EQNR
$96.3B
| $6.59M | ﹤0.01% |
+199,092
| New | +$7.18M |
|
1144
StepStone Group
STEP
$3.96B
| $6.57M | ﹤0.01% |
268,048
-5,169,720
| -95% | -$141M |
|
1145
Barings BDC
BBDC
$966M
| $6.56M | ﹤0.01% |
793,384
+1,033
| +0.1% | +$9.98K |
|
1146
Bentley Systems
BSY
$10.8B
| $6.55M | ﹤0.01% |
213,977
+17,038
| +9% | +$623K |
|
1147
WSFS Financial
WSFS
$4.15B
| $6.51M | ﹤0.01% |
140,091
-3,084,516
| -96% | -$144M |
|
1148
Morningstar
MORN
$7.41B
| $6.47M | ﹤0.01% |
30,461
+20,533
| +207% | +$4.88M |
|
|
SKX
1149
DELISTED
Skechers
SKX
| $6.45M | ﹤0.01% |
203,404
-2,580,897
| -93% | -$96.6M |
|
1150
First Solar
FSLR
$24.4B
| $6.4M | ﹤0.01% |
48,398
+1,346
| +3% | +$144K |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.